InvestorsHub Logo
Followers 0
Posts 178
Boards Moderated 0
Alias Born 12/04/2013

Re: jamtomorrow2 post# 5043

Friday, 12/30/2016 9:45:15 AM

Friday, December 30, 2016 9:45:15 AM

Post# of 8702
Minninv - HALO certainly needs some good news on the Enhanze program after a hugely disappointing 2016. With Bococizumab, Rivipansel and Humira all having been dropped by Pfizer and Abbvie and the Keytruda trial having been held up by a halt for bleeding, the pipeline is looking decidedly weaker than it was 12 months ago. The much touted 150 potential target drugs for HALOisation just don't seem to be progressing at all. And Shire doesn't seem to be actively promoting HyQ yet for reasons only known to themselves. The only good news is that Roche have applied for SQ Mabthera approval in the US (at last) although surprisingly not for SQ Herceptin.

So what is the good news that you are expecting?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News